Omicron sublineage BQ. 1.1 resistance to monoclonal antibodies
P Arora, A Kempf, I Nehlmeier, SR Schulz… - The Lancet Infectious …, 2023 - thelancet.com
Vaccination represents the key strategy to control the COVID-19 pandemic through induction
of neutralising antibody responses and T cellassociated immunitythat substantially decrease …
of neutralising antibody responses and T cellassociated immunitythat substantially decrease …
Effect of vaccination against SARS-CoV-2 on long COVID-19: a narrative review
Vaccines against SARS-CoV-2 have saved millions of lives and played an important role in
containing the COVID-19 pandemic. Vaccination against SARS-CoV-2 is also associated …
containing the COVID-19 pandemic. Vaccination against SARS-CoV-2 is also associated …
COVID-19: variants, immunity, and therapeutics for non-hospitalized patients
CYS Lee, JB Suzuki - Biomedicines, 2023 - mdpi.com
The continuing transmission of coronavirus disease 2019 (COVID-19) remains a world-wide
21st-century public health emergency of concern. Severe acute respiratory syndrome …
21st-century public health emergency of concern. Severe acute respiratory syndrome …
Associations of COVID-19 symptoms with omicron subvariants BA. 2 and BA. 5, host status, and clinical outcomes in Japan: a registry-based observational study
S Nakakubo, N Kishida, K Okuda… - The Lancet Infectious …, 2023 - thelancet.com
Summary Background Previous SARS-CoV-2 infection and vaccination, coupled with the
rapid evolution of SARS-CoV-2 variants, have modified COVID-19 clinical manifestations …
rapid evolution of SARS-CoV-2 variants, have modified COVID-19 clinical manifestations …
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
DM Skowronski, SE Kaweski, MA Irvine, S Kim… - Cmaj, 2022 - Can Med Assoc
Background: The evolving proportion of the population considered immunologically naive
versus primed for more efficient immune memory response to SARS-CoV-2 has implications …
versus primed for more efficient immune memory response to SARS-CoV-2 has implications …
[HTML][HTML] SARS-CoV-2 infection following booster vaccination: illness and symptom profile in a prospective, observational community-based case-control study
Background Booster COVID-19 vaccines have shown efficacy in clinical trials and
effectiveness in real-world data against symptomatic and severe illness. However, some …
effectiveness in real-world data against symptomatic and severe illness. However, some …
Effectiveness of COVID-19 vaccination on transmission: A systematic review
A Oordt-Speets, J Spinardi, C Mendoza, J Yang… - COVID, 2023 - mdpi.com
Vaccination against infectious disease affords direct protection from vaccine-induced
immunity and additional indirect protection for unvaccinated persons. A systematic review …
immunity and additional indirect protection for unvaccinated persons. A systematic review …
Epidemiological features of SARS-CoV-2 Omicron infection under new control strategy: a cross-sectional study of the outbreak since December 2022 in Sichuan …
R Liu, Y Zhang, J Ma, H Wang, Y Lan, X Tang - BMC Public Health, 2023 - Springer
Background A major shift in the “dynamic zero-COVID” policy was announced by China's
National Health Commission on December 7, 2022, and the subsequent immediate large …
National Health Commission on December 7, 2022, and the subsequent immediate large …
Increased SARS-CoV-2 seroprevalence and spread of infection without awareness among healthcare workers through 2020–2022 in a Japanese medical center
R Kanamori, Y Yan, K Ito, H Fukuda, S Hori… - Scientific Reports, 2023 - nature.com
Despite Japan's high vaccination coverage, daily numbers of new COVID-19 cases have
been high. However, studies on the seroprevalence among Japanese people and the …
been high. However, studies on the seroprevalence among Japanese people and the …
Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concern
Background COVID-19 vaccines used in humans are highly effective in limiting disease and
death caused by the SARS-CoV-2 virus, yet improved vaccines that provide greater …
death caused by the SARS-CoV-2 virus, yet improved vaccines that provide greater …